Glenmark, Lupin and 1 other recall products in US over manufacturing issues Ruchika Sharma11 April 2024 3:02 PM ISTNew Delhi: Glenmark, Lupin, and Natco Pharma, key players in the generic drug industry, are recalling products in the American market due to...
Boehringer Ingelheim Biopharmaceuticals China receives nod for supply of EU, US markets Ruchika Sharma10 April 2024 4:40 PM ISTBoehringer Ingelheim Biopharmaceuticals China (BioChina), in collaboration with a customer, has successfully passed pre-approval inspections by the...
Lupin unveils first generic version of Oracea in US Ruchika Sharma10 April 2024 11:15 AM ISTMumbai: Global pharma major Lupin Limited has announced the launch of first generic version of Oracea (Doxycycline Capsules, 40 mg), in the...
Many cancer drugs remain unproven 5 years after accelerated approval, says Study Roshni Dhar9 April 2024 5:34 PM ISTThe promise of early access to potentially life-saving drugs through the US Food and Drug Administration's accelerated approval program often comes...
Health Bulletin 09/ April/ 2024 Roshni Dhar9 April 2024 5:05 PM ISTHere are the top health news for the day:Delhi's Health Infrastructure 10 Key Takeaways from Panel's RecommendationsTaking note of problems affecting...
Natco Pharma Kothur facility gets USFDA warning letter Ruchika Sharma9 April 2024 2:27 PM ISTHyderabad: Natco Pharma has received a Warning Letter from the United States Food and Drug Administration (USFDA) for its Pharma Division...
Strides Pharma Science Singapore arm gets USFDA nod for Major Depressive Disorder drug Fluoxetine Ruchika Sharma9 April 2024 12:30 PM ISTThe product is bioequivalent and therapeutically equivalent to the Reference Listed Drug Prozac Tablets of Eli Lilly.
USFDA approves Lupin Valbenazine Capsules Ruchika Sharma9 April 2024 11:30 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug Administration (U.S....
Gland Pharma bags USFDA nod for breast cancer treatment injection Eribulin Mesylate Ruchika Sharma8 April 2024 11:36 AM IST"The Product is expected to be the first generic approval on the market, and the Company expects to launch this product in the near term through its...
FDA clears AI tool to detect heart failure with low ejection fraction Dr. Kamal Kant Kohli8 April 2024 9:00 AM ISTThe US Food and Drug Administration (FDA) has cleared first AI tool to detect heart failure with low ejection fraction. Eko Low Ejection Fraction...
Aurobindo Pharma arm gets 3 USFDA observations for AP injectable facility Ruchika Sharma7 April 2024 1:00 PM ISTHyderabad: In a recent BSE filing, Aurobindo Pharma has informed that the new injectable facility of Eugia Steriles Private Limited, a 100%...
USFDA approves Carvykti for patients with Relapsed or Refractory Multiple Myeloma who have received at least one prior line of therapy Ruchika Sharma7 April 2024 10:00 AM ISTHorsham: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved CARVYKTI (ciltacabtagene...
